You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mF-G score

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Psychological Status ofPatient Over 75 Years Old in Oncology

Not yet recruiting
  • Depression
    • Trévenans, France
      Hôpital Nord Franche-Comté
    Dec 28, 2022

    Oakland-Jairath Score Validation

    Recruiting
    • Lower Gastrointestinal Bleeding
    • Oakland-Jairath Risk Score
    • Edmonton, Alberta, Canada
    • +3 more
    Apr 5, 2022

    Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in

    Recruiting
    • Primary Myelofibrosis (PMF)
    • +2 more
    • Birmingham, Alabama
    • +155 more
    Aug 12, 2022

    Development ofNew Canadian Endourology Group Stent Symptom Score

    Recruiting
    • Urologic Diseases
    • CEGSSS-Canadian Endourology Group Stent Symptom Score
    • Los Angeles, California
    • +8 more
    Jul 26, 2022

    Measurement Information System-29 v2.1 for Postpartum Women

    Not yet recruiting
    • Well-Being, Psychological
    • PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System)
    • +2 more
    • Toronto, Ontario, Canada
      Mount Sinai Hospital
    Aug 16, 2023

    Prostate Cancer Trial in Ann Arbor, Detroit, Holland (Decipher, Prolaris, Oncotype Dx Genomic Prostate Score (GPS))

    Recruiting
    • Prostate Cancer
    • Decipher
    • +3 more
    • Ann Arbor, Michigan
    • +3 more
    Oct 26, 2021

    Influenza Trial in Canada (aTIV Primer, QIV Primer, aTIV Booster)

    Completed
    • Influenza
    • aTIV Primer
    • +3 more
    • Vancouver, British Columbia, Canada
    • +3 more
    Jan 28, 2022

    Interstitial Lung Disease Trial in Québec (Saturation at home)

    Recruiting
    • Interstitial Lung Disease
    • Saturation at home
    • Québec, Canada
      Centre de recherche de l'Institut universitaire de cardiologie e
    Sep 29, 2021

    D-dimer and Pre-test Clinical Probability Score in Cancer

    Completed
    • Deep Vein Thrombosis
    • Diagnostic tests for suspected deep vein thrombosis
    • Chieti, Italy
      Universita degli Studi G. d'Annunzio Chieti e Pescara
    Jul 14, 2021

    Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +148 more
    Oct 10, 2022

    Financial Toxicity and Quality of Life in Patients With TGCT

    Recruiting
    • Testicular Neoplasm
    • Comprehensive Score for financial toxicity (COST)
    • +3 more
    • San Antonio, Texas
      Mays Cancer Center
    Mar 30, 2022

    Mycosis Fungoides Trial in Leiden (Chlormethine)

    Recruiting
    • Mycosis Fungoides
    • Leiden, Netherlands
      Centre for Human Drug Research
    Mar 29, 2022

    Graves Disease Trial in Göteborg (MF course, Usual health care)

    Recruiting
    • Graves Disease
    • MF course
    • Usual health care
    • Göteborg, Sweden
      Agneta Lindo
    Nov 17, 2023

    Hip Osteoarthritis, Hip Disease Trial in Bologna (Micro-fragmented adipose tissue injection)

    Not yet recruiting
    • Hip Osteoarthritis
    • Hip Disease
    • Micro-fragmented adipose tissue injection
    • Bologna, Italy
      Istituto Ortopedico Rizzoli
    Jul 21, 2022

    Pneumonia Trial in France, Tunisia (PRISTINAMYCIN XRP7263, Amoxicillin, Amoxicillin Placebo)

    Recruiting
    • Pneumonia
    • PRISTINAMYCIN XRP7263
    • +3 more
    • Avoine, France
    • +18 more
    Jan 9, 2023

    Lung Cancer, Non Small Cell Lung Cancer, NSCLC Stage I Trial in Canada (Selective Targeted Sampling, Systematic Sampling)

    Completed
    • Lung Cancer
    • +3 more
    • Selective Targeted Sampling
    • Systematic Sampling
    • Edmonton, Alberta, Canada
    • +6 more
    Jul 25, 2022

    Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

    Recruiting
    • Myelofibrosis
    • La Jolla, California
    • +165 more
    Aug 19, 2022

    Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

    Recruiting
    • Myelofibrosis
    • Los Angeles, California
    • +41 more
    Jan 30, 2023

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    HF - Heart Failure Trial in Italy (CPET and related variables evaluation)

    Recruiting
    • HF - Heart Failure
    • CPET and related variables evaluation
    • Milano, Milan, Italy
    • +3 more
    Oct 2, 2023

    Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority

    Recruiting
    • Prostate Cancer
    • +2 more
    • Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
    • +7 more
    • Quebec, Canada
      CHUdeQuebec
    Apr 7, 2023

    Myelofibrosis (MF) Trial in Worldwide (Navitoclax, Ruxolitinib, Best Available Therapy (BAT))

    Recruiting
    • Myelofibrosis (MF)
    • Chandler, Arizona
    • +207 more
    Jul 26, 2022

    Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

    Suspended
    • Myelofibrosis
    • Adelaide, South Australia, Australia
    • +37 more
    Aug 18, 2022

    Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

    Recruiting
    • Iron Deficiency Anemia
    • Adelaide, South Australia, Australia
    • +8 more
    Jun 23, 2023